Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes
Go back to Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes| DexCom, Inc. (NASDAQ: DXCM) | Delayed: 85.56 -2.34 (2.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $87.90 | 52 Week High | $96.38 | |||
| Open | $86.59 | 52 Week Low | $47.92 | |||
| Day High | $86.61 | P/E | N/A | |||
| Day Low | $85.29 | EPS | $-0.42 | |||
| Volume | 174,478 | |||||

